Pfizer, Inc. vs Zimmer Biomet Holdings, Inc. — Stock Comparison

PFE
Pfizer, Inc.
$26.33
▼ 1.39%
vs
ZBH
Zimmer Biomet Holdings, Inc.
$82.90
▲ 0.57%
Q·Score Winner
Zimmer Biomet Holdings, Inc.
ZBH6.9/10vs 6.5/10

Q·Score Breakdown

6.5
Neutral
Overall
6.9
Neutral
7.4
Quality
6
7
Health
7.6
5.6
Growth
8.8
6.7
Valuation
7.1
5.2
Sentiment
4.8
PFE

Strong profitability with 12% net profit margins.

analyst sentiment is cautious.

ZBH

Earnings growing 34% year-over-year on 9% revenue growth.

cautious analyst consensus — few Buy ratings.

Analyst Consensus

HOLD
Target $29.00 (+10.2%)
27 analysts
HOLD
Target $98.52 (+18.8%)
21 analysts

Fundamentals

PFE
ZBH
19.4×
Trailing P/E
21.5×
9.4×
Forward P/E
9.2×
12.4%
Profit Margin
9.1%
75.8%
Gross Margin
70.2%
8.9%
ROE
6.1%
-1.2%
Revenue Growth
9.3%
Earnings Growth
34.1%
0.39
Beta
0.61
Price / Book
$149.8B
Market Cap
$16.0B
$22 – $29
52-Week Range
$80 – $108

Q·Score is an educational tool and is not financial advice. Data provided by Yahoo Finance. Updated on each page load. How it's calculated →